Personalized Breast Cancer Treatment
101 – 110 of 148
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
- Contribution to journal › Article
-
Mark
Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
- Contribution to journal › Published meeting abstract
-
Mark
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
- Contribution to journal › Article
-
Mark
High-throughput molecular techniques and personalized treatment for primary breast cancer
(2018)
- Thesis › Doctoral thesis (compilation)
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
- Contribution to journal › Article
-
Mark
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
- Contribution to journal › Article
